Skip to main content

Incidence of Hospitalization for ACS or Coronary Revascularization in Patients With Type 2 Diabetes Treated With Once Weekly GLP-1 Receptor Agonist Exenatide

Publication ,  Conference
Barbery, C; White, J; Lokhnygina, Y; Mentz, RJ; Hernandez, AF; Holman, R; Jones, WS
Published in: CIRCULATION
2019

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2019

Volume

140

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Barbery, C., White, J., Lokhnygina, Y., Mentz, R. J., Hernandez, A. F., Holman, R., & Jones, W. S. (2019). Incidence of Hospitalization for ACS or Coronary Revascularization in Patients With Type 2 Diabetes Treated With Once Weekly GLP-1 Receptor Agonist Exenatide. In CIRCULATION (Vol. 140).
Barbery, Carlos, Jennifer White, Yuliya Lokhnygina, Robert J. Mentz, Adrian F. Hernandez, Rury Holman, and William S. Jones. “Incidence of Hospitalization for ACS or Coronary Revascularization in Patients With Type 2 Diabetes Treated With Once Weekly GLP-1 Receptor Agonist Exenatide.” In CIRCULATION, Vol. 140, 2019.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2019

Volume

140

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology